MetLife Investment Management, LLC
Position in RXRX — Recursion Pharmaceuticals, Inc.
CIK 1529735
Whippany, NJ
Position in RXRX
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$772,141
-$85,945 QoQ
Shares Held
251,512
+19.9% QoQ
Ownership
0.047%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RXRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MetLife Investment Management, LLC holds $374,315,342 across 207 Biotechnology names. RXRX ranks #81 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
70,804 | $31,616,818 | |
| 2 | PRAX |
Praxis Precision Medicines, Inc.
|
80,930 | $26,074,836 | |
| 3 | AXSM |
Axsome Therapeutics, Inc.
|
152,645 | $25,800,057 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
374,931 | $24,231,790 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
23,567 | $18,208,806 | |
| 6 | FTRE |
Fortrea Holdings Inc.
|
1,805,184 | $17,004,833 | |
| 7 | ADMA |
Adma Biologics, Inc.
|
1,738,062 | $15,659,938 | |
| 8 | VRDN |
Viridian Therapeutics, Inc.\DE
|
708,527 | $13,858,788 |
All Filings in RXRX
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $772,141 | 251,512 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $858,086 | 209,801 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $1,050,371 | 215,240 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,032,644 | 204,080 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $782,957 | 148,007 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $1,012,702 | 149,808 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $899,805 | 136,541 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $901,020 | 120,136 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $719,445 | 72,161 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $711,507 | 72,161 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $552,031 | 72,161 | Shares | Defined | 2024-05-09 | |
| 2023-06-30 | $539,042 | 72,161 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $481,313 | 72,161 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $556,361 | 72,161 | Shares | Defined | 2023-03-23 | |
| 2022-09-30 | $767,793 | 72,161 | Shares | Defined | 2023-03-23 | |
| 2022-06-30 | $587,390 | 72,161 | Shares | Defined | 2023-03-23 | |
| 2022-03-31 | $458,490 | 64,035 | Shares | Defined | 2023-03-23 | |
| 2021-12-31 | $705,790 | 41,202 | Shares | Defined | 2023-03-23 | |
| 2021-09-30 | $247,380 | 10,751 | Shares | Defined | 2023-03-23 | |
| 2021-06-30 | $317,842 | 8,708 | Shares | Defined | 2023-03-23 | |
| No filing history on record for this holder in this stock. | ||||||